Azvudine for the Treatment of COVID‐19 in Pre‐Existing Cardiovascular Diseases: A Single‐Center, Real‐World Experience

Abstract COVID‐19 can lead to adverse outcomes in patients with pre‐existing diseases. Azvudine has been approved for treating COVID‐19 in China, but the real‐world data is limited. It is aimed to investigate the efficacy of Azvudine in patients with COVID‐19 and pre‐existing cardiovascular diseases...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Liu Wu, Zhong‐Han He, Ling Huang, Xin Guo, Xu‐Yong Li, Hong‐Da Zhang, Man‐Hua Chen
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2024-06-01
coleção:	Advanced Science
Assuntos:	Azvudine cardiovascular diseases COVID‐19 death outcome
Acesso em linha:	https://doi.org/10.1002/advs.202306050
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!